Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.3.3 was added to the page's revision history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedNew history entry added for 2025-11-25 (Revision: v3.3.2). An older entry (Revision: v3.3.1) was deleted on 2025-11-17.SummaryDifference0.0%

- Check45 days agoChange DetectedVersion 3.3.1 (2025-11-17) adds Contacts/Locations and Study Status to the record, replacing version 3.2.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the government funding status notice from the page. The rest of the study history and content remain unchanged.SummaryDifference0.0%

- Check67 days agoChange DetectedVersion 678 was posted on 2025-10-28 and adds updates to Study Status and Contacts/Locations, while a deletion occurred on 2025-10-20.SummaryDifference0.0%

- Check96 days agoChange DetectedUpdate: version revision changed from v3.0.2 to v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.